THE IMPACT OF ELEVATED SERUM IgA AND RACE ON PRIMARY RECIPIENT RENAL ALLOGRAFT SURVIVAL 1
Authors:
- 27 January 1996
- journal article
- research article
- Published by Wolters Kluwer Health in Transplantation
- Vol. 61 (2) , 205-211
Abstract
This study correlated overall serum IgA levels in pretransplant(preTx) sera with graft survival. IgA levels, determined by nephelometry, were normally distributed, with a mean level of 255±139 mg/dl and a median of 234 mg/dl in 631 adult primary kidney allograft recipients and a mean level of 213±123 mg/dl with a median of 196 mg/dl for 100 retransplant recipients. Improved 3-year survival was associated with a high preTx IgA serum level in primary recipients (Kaplan-Meier analysis,P=0.01), but not in retransplant patients. After stratifying by race, IgA correlated with graft survival in Caucasian, Hispanic, and “other” (Middle Eastern, Indian subcontinent, and Asian) primary recipients (P≤0.04), but not in African Americans. Higher survival rates were not associated with IgA in primary recipients stratified for rejection episodes, blood transfusions, or HLA-DR mismatches. Graft survival was improved in patients with >2 HLA-AB mismatches and serum IgA above the median. PreTx IgA level and IgA α-HLA activity were significantly associated in preTx sera of primary renal allograft recipients (χ2=7.145,P=0.01), although only 9% (12/133) of sera tested displayed IgA anti-HLA class I reactivity. Thus, enhanced graft survival mediated by elevated serum IgA levels may due in part to competition for allograft HLA class I binding with deleterious Ig subclasses or immune effector cells. Elevated serum IgA may also reflect an altered immunoregulatory state. The results suggest that, depending on the racial group, preTx serum IgA levels are a prognostic indicator of graft survival in primary renal allograft recipients.Keywords
This publication has 23 references indexed in Scilit:
- Detection of panel-reactive anti-HLA class I antibodies by enzyme-linked immunosorbent assay or lymphocytotoxicityHuman Immunology, 1995
- Association of IgA‐anti‐Fab autoantibodies with disease stage in head‐and‐neck cancerInternational Journal of Cancer, 1994
- CHARACTERIZATION OF ANTIIDIOTYPIC ANTIBODIES TO DONOR HLA THAT DEVELOP AFTER LIVER TRANSPLANTATIONTransplantation, 1993
- THE ASSOCIATION OF KIDNEY GRAFT OUTCOME WITH PRETRANSPLANT SERUM IgG-ANTI-F(AB')2γ ACTIVITYTransplantation, 1992
- THE ABILITY OF PRETRANSPLANT TEST-DOSE PHARMACOKINETIC PROFILES TO REDUCE EARLY ADVERSE EVENTS AFTER RENAL TRANSPLANTATION1, 2Transplantation, 1992
- IgA nephropathy in Blacks: Studies of IgA2 allotypes and clinical courseKidney International, 1991
- Antiidiotypic antibodies to HLA class I alloantibodies in normal individuals: A mechanism of tolerance to noninherited maternal HLA antigensHuman Immunology, 1991
- OPTIMIZATION OF CYCLOSPORINE THERAPY IN RENAL TRANSPLANTATION BY A PHARMACOKINETIC STRATEGYTransplantation, 1988
- IMMUNOLOGICAL ENHANCEMENT CAN BE MEDIATED BY ANTI-Ia AND ANTI-K,D ANTIBODIESTransplantation, 1980
- IMMUNE REACTIVITY OF CELLS FROM LONG-TERM RAT RENAL ALLOGRAFT SURVIVORSTransplantation, 1978